RESULTS. : Biopsy-proven glomerular disease recurrence was similar in patients induced with alemtuzumab or IL-2 receptor antagonists.
结果：在用阿仑单抗治疗或白细胞介素-2受体拮抗剂治疗患者中的活组织检查出肾小球疾病复发率相似。
2
Starting about a week before the transplant, the patients also received a drug called alemtuzumab which destroyed circulating native white blood cells so they couldn't attack the transplanted cells.